id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
655308,1cfda4d0-0e91-4ac4-9727-96bc7ecea577,Q2,BIOTECHNOLOGY INNOVATION ORGANIZATION,6245,BIOTECHNOLOGY INNOVATION ORGANIZATION,2008,second_quarter,CPT,"Patent Reform
    H.R. 1908 
    S. 1145 CBD TRIPS Amendment
     Patent Disclosure Requirements 

PTO Proposed Regulations
     Continuation Rules: FR 2005-P-066
     Claims Rules: FR 2005-P-067
     Information Disclosure Rules: 71-FR-38808
     Biologic Deposit Rule: 73-FR-34  

Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World
      U.S. Government Positions in WTO, WHO Negotiations 

Bayh-Dole Act Evaluation  

Intellectual Property Enforcement      

Gene Patenting  

Intellectual Property Provisions in U.S. Trade Agreements
      Korean Trade Agreement","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Council of Economic Advisers (CEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR),White House Office",,1920000,0,0,2008-07-21T18:55:10-04:00